Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Jade Biosciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +23 vs. Q2 2021
- Shares held
- 21.7M
- +1.69M (+8.5%) vs. Q2 2021
- Total value
- $452.6M
- −$1.85M (−0.4%) vs. Q2 2021
- New holders
- 29
- 3 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $173.4M | 2.40% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $78.9M | 5.06% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,030,691 | $42.0M | 1.71% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,652,171 | $34.7M | 0.15% | +223,600+15.7% | Added |
| Citadel Advisors LLC | 1,594,813 | $32.4M | 0.04% | −20,185−1.2% | Reduced |
| Vanguard Group Inc | 781,375 | $16.4M | 0.00% | +781,375 | New |
| FMR LLC | 718,351 | $15.1M | 0.00% | −177,466−19.8% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 714,285 | $15.0M | 0.29% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 535,714 | $11.2M | 0.12% | 00.0% | Unchanged |
| BlackRock Inc. | 483,018 | $10.1M | 0.00% | +483,018 | New |
| Sectoral Asset Management Inc | 341,367 | $7.16M | 0.60% | −158,633−31.7% | Reduced |
| Parametric Portfolio Associates LLC | 141,638 | $2.97M | 0.00% | +141,638 | New |
| State Street Corp | 125,843 | $2.64M | 0.00% | +125,843 | New |
| Geode Capital Management, LLC | 114,423 | $2.40M | 0.00% | +114,423 | New |
| Northern Trust Corp | 88,205 | $1.85M | 0.00% | +88,205 | New |
| Millennium Management LLC | 69,867 | $1.47M | 0.00% | +4,824+7.4% | Added |
| Point72 Asset Management, L.P. | 53,872 | $1.13M | 0.01% | +53,872 | New |
| Parkwood LLC | 48,059 | $1.01M | 0.17% | +48,059 | New |
| Charles Schwab Investment Management Inc | 24,736 | $519.0K | 0.00% | +24,736 | New |
| Bank of New York Mellon Corp | 21,791 | $457.0K | 0.00% | +21,791 | New |
| Nuveen Asset Management, LLC | 14,318 | $300.0K | 0.00% | +14,318 | New |
| Chicago Partners Investment Group LLC | 16,076 | $284.0K | 0.02% | +16,076 | New |
| Old Well Partners, LLC | 12,600 | $264.0K | 0.14% | +12,600 | New |
| Darwin Global Management, Ltd. | 12,484 | $262.0K | 0.05% | +12,484 | New |
| Deutsche Bank AG | 5,794 | $122.0K | 0.00% | +5,794 | New |
| American International Group, Inc. | 5,515 | $116.0K | 0.00% | +5,515 | New |
| California State Teachers Retirement System | 5,445 | $114.0K | 0.00% | +5,445 | New |
| JPMorgan Chase & Co | 5,242 | $110.0K | 0.00% | +5,242 | New |
| Morgan Stanley | 2,741 | $57.0K | 0.00% | +2,741 | New |
| STRS Ohio | 2,300 | $48.0K | 0.00% | +2,300 | New |
| New York State Common Retirement Fund | 1,800 | $38.0K | 0.00% | +1,800 | New |
| Royal Bank of Canada | 1,254 | $27.0K | 0.00% | +1,254 | New |
| Citigroup Inc | 1,149 | $24.0K | 0.00% | +1,149 | New |
| UBS Group AG | 1,091 | $23.0K | 0.00% | −959−46.8% | Reduced |
| Legal & General Group Plc | 941 | $20.0K | 0.00% | +941 | New |
| Bank of America Corp | 881 | $18.0K | 0.00% | +881 | New |
| Ameritas Investment Partners, Inc. | 772 | $16.0K | 0.00% | +772 | New |
| Cubist Systematic Strategies, LLC | 775 | $16.0K | 0.00% | +775 | New |
| Tower Research Capital LLC (TRC) | 414 | $9.00K | 0.00% | +179+76.2% | Added |
| Point72 Hong Kong Ltd | 285 | $6.00K | 0.00% | +285 | New |
| Wells Fargo & Company | 55 | $1.00K | 0.00% | +55 | New |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −104,755−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −21,070−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −9,854−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Kelly Financial Services LLC | 0 | $0 | 0.00% | −91−100.0% | Sold out |